{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rheumatoid arthritis: New treatments, better outcomes
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
The purpose of this learning activity is to provide information about advances in treating RA.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify current practice recommendations for treating RA.
- Discuss new drug therapies for RA.
Disclosures
The author and planners have disclosed that they have no financial relationships related to this article.
Price:
$24.95
Credits:
- ANCC 2.5 CH / 2.5 APH
- DC - BON 2.5 CH
- KY-BON 2.5 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.--------------------------------------------------This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.--------------------------------------------------The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
Awarded Advanced Pharmacology Hours.
Awarded Advanced Pharmacology Hours.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: NP1112A
Published: November 2012
Expires: 12/31/2026
Required Passing Score: 13/18 (72%)
Specialties:
Medical-Surgical